Profits and Promotion Under Attack
Article
Pharmaceutical Executive
Pharmaceutical ExecutivePharmaceutical Executive-09-01-2001
Volume 0
Issue 0
As policy makers struggle to devise a pharmacy benefit for Medicare patients, pressure mounts to impose spending limits on medications. In turn, consumer activists are challenging industry’s longtime claim that price controls will reduce investment in R&D for life-saving therapies.
Articles in this issue
Profits and Promotion Under Attack
Church and State
Document Leak: NICE Says No to MS
Business Disposal: GSK Dumps Affymax
Criticism: Pharma Goes on the Attack
New Playing Fields
Inefficiencies: Cutting Through the Jungle
Legislation: EC Proposes Changes
Flexing Their Budgets: Big Pharma Spend Trends
Media Mix Town Meeting 2001: Much Ado About Media
Recent Videos
Related Content
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Podcast
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
